Literature DB >> 25579512

Regulatory mechanisms and clinical perspectives of miR-34a in cancer.

Lei Li1.   

Abstract

MicroRNAs (miRNAs) are evolutionarily conserved, endogenous, noncoding RNA molecules of about 22-24 nucleotides in length that repress gene expression at the posttranscriptional level. MiR-34a plays an important role in the initiation, progression, and therapy of cancer. In addition, the miR-34a expression has also been identified as a diagnostic and prognostic cancer signature. This article introduces the roles of miR-34a in cancer development, metastasis as well as its mechanism of actions on target genes and the functional outcomes of its actions on radio-sensitivity. The paper ends with a brief perspective to the future of miR-34a.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25579512     DOI: 10.4103/0973-1482.146084

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  12 in total

1.  miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma.

Authors:  Ting-Yi Sun; Hong-Jian Xie; Zhen Li; Ling-Fei Kong; Xiang-Nan Gou; Du-Juan Li; Yu-Jie Shi; Yan-Zhi Ding
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

2.  Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition.

Authors:  Maryam Hosseini; Kaveh Baghaei; Davar Amani; Masoumeh Ebtekar
Journal:  Daru       Date:  2021-08-17       Impact factor: 4.088

3.  The miRNA-34a/Sirt1/p53 pathway in a rat model of lens regeneration.

Authors:  Xue Bi; Rui Wang; Hui Song; Yuchuan Wang; Peng Hao; Xuan Li
Journal:  Ann Transl Med       Date:  2022-06

4.  Could miR-34a Inhibition be Used as a Tool to Overcome Drug Resistance in MCF-7 Cells Treated with Synthesized Steroidal Heterocycles?

Authors:  Shaymaa M M Yahya; Mervat M Abd-Elhalim; Abdou O Abdelhamid; Emad F Eskander; Ghada H Elsayed
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

Review 5.  MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.

Authors:  Ammad Ahmad Farooqi; Sobia Tabassum; Aamir Ahmad
Journal:  Int J Mol Sci       Date:  2017-10-02       Impact factor: 5.923

6.  MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.

Authors:  Ai-Hua Chen; Yu-E Qin; Wen-Fan Tang; Jing Tao; Hua-Mei Song; Manzhen Zuo
Journal:  Cancer Cell Int       Date:  2017-06-09       Impact factor: 5.722

7.  MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2.

Authors:  Tamara V Werner; Martin Hart; Ruth Nickels; Yoo-Jin Kim; Michael D Menger; Rainer M Bohle; Andreas Keller; Nicole Ludwig; Eckart Meese
Journal:  Aging (Albany NY)       Date:  2017-03-23       Impact factor: 5.682

8.  Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.

Authors:  Hsiuying Wang
Journal:  Int J Mol Sci       Date:  2016-05-19       Impact factor: 5.923

9.  MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.

Authors:  Eman A Toraih; Afaf T Ibrahiem; Manal S Fawzy; Mohammad H Hussein; Saeed Awad M Al-Qahtani; Aly A M Shaalan
Journal:  Oxid Med Cell Longev       Date:  2017-09-20       Impact factor: 6.543

10.  miR-34a regulates adipogenesis in porcine intramuscular adipocytes by targeting ACSL4.

Authors:  Wenwen Wang; Xiuxiu Li; Ning Ding; Jun Teng; Shen Zhang; Qin Zhang; Hui Tang
Journal:  BMC Genet       Date:  2020-03-14       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.